MoneyWorks4Me

The sales is pegged at Rs. 656.35 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 731.27 millions during the year-ago period.The Net Profit of the company registered a slight decline of -9.50% to Rs. 3.24  millions from Rs. 3.58 millions.Operating profit surged to 68.95 millions from the corresponding previous quarter of 68.48 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 656.35 731.27 -10.25 656.35 731.27 -10.25 3024.96 3385.40 -10.65
Other Income 7.41 2.85 160.00 7.41 2.85 160.00 21.49 23.03 -6.69
PBIDT 68.95 68.48 0.69 68.95 68.48 0.69 322.26 338.29 -4.74
Interest 40.52 37.06 9.34 40.52 37.06 9.34 168.45 144.61 16.49
PBDT 28.43 31.42 -9.52 28.43 31.42 -9.52 153.81 193.68 -20.59
Depreciation 25.19 24.26 3.83 25.19 24.26 3.83 96.49 100.49 -3.98
PBT 3.24 7.16 -54.75 3.24 7.16 -54.75 57.32 93.19 -38.49
TAX 0.00 3.58 0.00 0.00 3.58 0.00 -20.67 15.94 -229.67
Deferred Tax 0.00 -1.90 0.00 0.00 -1.90 0.00 -19.27 8.38 -329.95
PAT 3.24 3.58 -9.50 3.24 3.58 -9.50 77.99 77.25 0.96
Equity 159.21 158.04 0.74 159.21 158.04 0.74 159.21 158.04 0.74
PBIDTM(%) 10.51 9.36 12.18 10.51 9.36 12.18 10.65 9.99 6.61

Bal Pharma Share Price

85.69 -0.86 (-0.99%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: